US Patent 7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
Patent 7297792 was granted and assigned to Smithkline Beecham Limited on November, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+70 characters)
Article
Patent abstract
The present invention includes compound of formula (I),
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics US Patent 7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
Infobox
Patent Number
0729779200
Patent Number
729779200
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072977920
Date of Patent
November 20, 2007
0Patent Application Number
114223380
Date Filed
June 6, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072977920
Date of Patent
November 20, 2007
0Patent Application Number
114223380
Date Filed
June 6, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07297792
Date of patent
November 20, 2007
Patent application number
11422338
Date Filed
June 6, 2006
Patent primary examiner
Find more entities like US Patent 7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
